Regeneron quarterly profit slumps as COVID antibody sales dry up

The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, US September 17, 2020. Picture taken September 17, 2020. REUTERS/Brendan McDermid/File Photo Register now for FREE unlimited access to Reuters.com Register Aug 3 (Reuters) – Regeneron Pharmaceuticals (REGN.O) reported a 72.5% fall in quarterly profit on … Read more

Sanofi lifts profit outlook as Dupixent sales surge over 43%

Sanofi logo at the company’s headquarters during the annual results news conference in Paris, France, February 4, 2022. REUTERS/Benoit Tessier/ Register now for FREE unlimited access to Reuters.com Register July 28 (Reuters) – French healthcare group Sanofi (SASY.PA) lifted its full-year earnings outlook on continued strong sales growth for its bestselling drug Dupixent. In a … Read more